🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is conducted to evaluate the efficacy and safety of Alflutinib i...
Status
Terminated
Location
cancer hospital Chinese academy of medical sciences
Start Date
2018-04-30
Trial ID
NCT03452592
Treatments Being Tested
The aim of this phase Ⅱ study is to evaluate the efficacy and safety of Fur...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-12-09
Trial ID
NCT05255406
Treatments Being Tested
The goal of phase Ib study was to evaluate efficacy and tolerability of the...
Status
Recruiting
Location
Ordos Central Hospital
Start Date
2025-04-08
Trial ID
NCT07087223
In this single-arm, phase II clinical trial, patients with resectable, EGFR...
Status
Active Not Recruiting
Location
Tangdu Hospital
Start Date
2022-02-24
Trial ID
NCT05430802
Treatments Being Tested
EGFR mutation positive advanced NSCLC patients with uncleared ctDNA have po...
Status
Recruiting
Location
The First Hospital of Jilin University
Start Date
2022-05-06
Trial ID
NCT05334277
The purpose of this study is to assess the Treatment Strategies and Surviva...
Status
Recruiting
Location
Yongchang Zhang
Start Date
2020-04-16
Trial ID
NCT04322890
Treatments Being Tested
This study is a Phase III, international, multicenter, randomized, controll...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-09-26
Trial ID
NCT06970639
This is a single-arm, exploratory phase Ib/II study with a seamless design ...
Status
Recruiting
Location
The Second Affiliated Hospital of Nanchang University
Start Date
2026-07-03
Trial ID
NCT07655622
Treatments Being Tested
Evaluate the efficacy and safety of neoadjuvant furmonertinib combined with...
Status
Not Yet Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2024-10-01
Trial ID
NCT06585644
Treatments Being Tested
This Phase II randomized study is to explore the efficacy and safety of Fur...
Status
Unknown
Location
Sun yat-sen University Cancer Center
Start Date
2021-06-01
Trial ID
NCT04970693
Treatments Being Tested